These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2076391)

  • 1. Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Nellessen U; Wiese B; Hugenholtz PG; Lichtlen PR
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1037-45. PubMed ID: 2076391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Computer-assisted geometric measuring technic in coronary angiography interval studies: results of initial angiograms of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT) study].
    Jost S; Deckers J; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Lippolt P; Hugenholtz PG; Lichtlen PR
    Z Kardiol; 1989 Jan; 78(1):23-32. PubMed ID: 2646838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Reiber JH; Nikutta P; Wiese B; Hugenholtz P; Lichtlen P
    Int J Card Imaging; 1990-1991; 6(2):117-33. PubMed ID: 2097305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Jost S; Deckers JW; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Hugenholtz PG; Lichtlen PR
    Int J Card Imaging; 1988; 3(2-3):75-86. PubMed ID: 3049846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of coronary stenoses is related to baseline severity--a prospective quantitative angiographic analysis in patients with moderate coronary disease. INTACT Investigators. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S; Deckers JW; Nikutta P; Wiese B; Rafflenbeul W; Hecker H; Lippolt P; Lichtlen PR
    Eur Heart J; 1994 May; 15(5):648-53. PubMed ID: 8056005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Nikutta P; Deckers JW
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1047-68. PubMed ID: 2076392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.
    Jost S; Deckers J; Rafflenbeul W; Reiber JH; Nikutta P; Wiese B; Hecker H; Lippolt P; Riedel M; Nolte CW
    Int J Card Imaging; 1993 Mar; 9(1):29-37. PubMed ID: 8491998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the selection of angiographic projections on the results of coronary angiographic follow-up trials. International Nifedipine Trial on Antiatherosclerotic Therapy Investigators.
    Jost S; Deckers J; Nikutta P; Reiber JH; Rafflenbeul W; Wiese B; Hecker H; Lichtlen P
    Am Heart J; 1995 Sep; 130(3 Pt 1):433-9. PubMed ID: 7661057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.
    Jost S; Rafflenbeul W; Deckers J; Wiese B; Hecker H; Nikutta P; Lippolt P; Lichtlen P
    Eur J Epidemiol; 1992 May; 8 Suppl 1():107-19. PubMed ID: 1505647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators.
    Jost S; Deckers JW; Nikutta P; Rafflenbeul W; Wiese B; Hecker H; Lippolt P; Lichtlen PR
    J Am Coll Cardiol; 1993 May; 21(6):1339-46. PubMed ID: 8473639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International nifedipine trial on antiatherosclerotic therapy (INTACT).
    Lichtlen PR; Nellessen U; Rafflenbeul W; Jost S; Hecker H
    Cardiovasc Drugs Ther; 1987; 1(1):71-9. PubMed ID: 3154311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of atherosclerotic plaque distribution in the left main coronary artery and proximal segments of left anterior descending and left circumflex arteries in patients qualified for percutaneous coronary angioplasty].
    Gziut AI
    Ann Acad Med Stetin; 2006; 52(2):51-62; discussion 62-3. PubMed ID: 17633397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.
    Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Deckers JW
    Lancet; 1990 May; 335(8698):1109-13. PubMed ID: 1971861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).
    Shinoda E; Yui Y; Kodama K; Hirayama A; Nonogi H; Haze K; Sumiyoshi T; Hosoda S; Kawai C;
    Hypertension; 2005 Jun; 45(6):1153-8. PubMed ID: 15851624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo.
    Ge J; Erbel R; Gerber T; Görge G; Koch L; Haude M; Meyer J
    Br Heart J; 1994 Jun; 71(6):572-8. PubMed ID: 8043342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. The Multicenter Anti-Atheroma Study (MAAS) Investigators.
    Vos J; de Feyter PJ; Kingma JH; Emanuelsson H; Legrand V; Winkelmann B; Dumont JM; Simoons LM
    Eur Heart J; 1997 Jul; 18(7):1081-9. PubMed ID: 9243140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).
    ENCORE Investigators
    Circulation; 2003 Jan; 107(3):422-8. PubMed ID: 12551866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation by high-frequency epicardial echocardiography of a new method of analyzing coronary angiography quantitatively in coronary artery disease.
    McPherson DD; Johnson MR; Collins SM; Kieso RA; Marcus ML; Kerber RE
    Am J Cardiol; 1993 Jan; 71(1):28-32. PubMed ID: 8420232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holistic polar map for integrated evaluation of cardiac imaging results.
    Koszegi Z; Balkay L; Galuska L; Varga J; Hegedus I; Fulop T; Balogh E; Jenei C; Szabo G; Kolozsvari R; Racz I; Edes I
    Comput Med Imaging Graph; 2007 Oct; 31(7):577-86. PubMed ID: 17714916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).
    Yui Y; Shinoda E; Kodama K; Hirayama A; Nonogi H; Haze K; Sumiyoshi T; Hosoda S; Kawai C;
    J Hypertens; 2007 Oct; 25(10):2019-26. PubMed ID: 17885543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.